The outpatient treatment of severe hypoglycemia in T1D, involving loss of consciousness and/or the inability to swallow, principally involves the administration of intramuscular, subcutaneous or intranasal glucagon. This evidence concerns the gene GCG and type 1 diabetes mellitus.